Cuba discusses women progress in the fight against COVID-19
Cuba on Thursday 4, discussed its experiences fighting COVID-19 at the forum ‘Feminist approaches on the pandemic and beyond,’ organized by the left-wing group at the European Parliament.
Emisora de Radio de Cienfuegos, Cuba
Cuba on Thursday 4, discussed its experiences fighting COVID-19 at the forum ‘Feminist approaches on the pandemic and beyond,’ organized by the left-wing group at the European Parliament.
Within a few days of starting phase III of clinical trials with 42,600 volunteers, Soberana 02 vaccine has been latest news domestically and internationally.
The national director of Epidemiology at Cuba’s Ministry of Public Health (MINSAP), Dr. Francisco Duran, announced the 60th National Oral Bivalent Vaccination Campaign against Polio, which will start on Monday 22 nationwide
The Australian edition of the digital media Bussines Insider, one of the leading voices of the so-called “business journalism” in Australia, reported last Monday the progress of Cuba in the development of its own vaccine candidates against COVID -19.
Cuba has registered four vaccine candidates against COVID-19 that are currently on clinical trials, after Mambisa and Abdala, developed by the Genetic Engineering and Biotechnology Center (CIGB), were authorized for this phase of the study.
The Cuban scientific community is currently working on a third COVID-19 vaccine candidate, the first needle-free injection that would be applied through the nasal tract.
Cuban Public Registry of Clinical Trials this Sunday just published a study that includes a new clinical trial with the «prophylactic vaccine candidate» against COVID-19, officially called «FINLAY-FR-1A», which would pass to be Soberana 01A
Cuban Deputy Prime Minister Roberto Morales Ojeda visited on Monday 21, the Finlay Vaccine Institute of Havana to monitor the progress of the ongoing projects in the center, especially the country’s vaccine against Covid-19, Soberana 01.
The continuous race for a COVID-19 vaccine triggered the development of around 180 vaccine candidates worldwide, of which 35 are currently in human trials.
Twenty more Cubans this Wednesday joined the second phase of Soberana 01 clinical study, Cuba’s first vaccine candidate against COVID-19.